Manufacturing and Production

Showing 15 posts of 5863 posts found.

Pfizer headquarters

NICE to take another look at Pfizer’s leukaemia drug

January 2, 2018 Manufacturing and Production, Sales and Marketing NICE, Pfizer, biotech, drugs, pharma, pharmaceutical

Back in August of 2017, NICE rejected Pfizer’s Besponsa on cost-effectiveness grounds and the pharma giant was not best pleased. …
dermapace-product

FDA approves shock wave wound healing device

January 2, 2018 Manufacturing and Production, Sales and Marketing FDA, biotech, drugs, pharma, pharmaceutical

Continuing its recent trend to promote innovative new technologies, the FDA has announced that it has approved a medical device …
mylan_building

Mylan and Biocon biosimilar approval expands to Brazil

January 2, 2018 Manufacturing and Production, Sales and Marketing Biocon, Herceptin, Mylan, biosimilar, biotech, drugs, pharma, pharmaceutical

Since Mylan and Biocon managed to gain US FDA approval for its Herceptin (Trastuzumab) biosimilar, it has forged ahead in …
valeant

Valeant and Pershing take $290m hit over insider trading

January 2, 2018 Manufacturing and Production, Sales and Marketing Bill Ackman, Pershing Square, Valeant, biotech, drugs, pharma, pharmaceutical

Valeant Pharmaceuticals will be hoping it can begin 2018 as a fresh start, after a turbulent few years, to say …
2018

Seven pharma trends for 2018

December 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2018, M&A, MA, biosimilars, collaborations, digital pharma, emerging markets, patient centricity, pharma, pricing

Pharmafile.com looks ahead to signpost what we expect will be the key industry trends through the course of 2018.The value of …
attribution-icon-2888829_640

The rare disease climate in Europe

December 21, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, rare disease

Continuing on from this week’s earlier feature on the rare disease situation in the US, Pharmafile moves its attention onto …
gsk_boronia_australia

GSK forced to pay back £1.5m to Scottish Government after recent job cuts

December 20, 2017 Manufacturing and Production, Research and Development GSK, GlaxoSmithKline, pharma

British pharmaceutical giant GlaxoSmithKline has been ordered to pay back £1.5 million to the Scottish Government because of its failure …
allergan

Allergan and Gedeon Richter’s Vraylar posts strong Phase 3 data in bipolar depression

December 19, 2017 Manufacturing and Production, Research and Development Allergan, Gedeon Richter, Vraylar, bipolar, bipolar depression, pharma

Vraylar (cariprazine), a drug developed as part of a partnership between Allergan and Gedeon Richter, has demonstrated strong results at …

Boehringer scoops schizophrenia candidates for €627.5m

December 19, 2017 Manufacturing and Production, Sales and Marketing Autifony, Boehringer Ingelheim, biotech, drugs, pharma, pharmaceutical

Boehringer Ingelheim has moved early to secure an exclusive option on Autifony’s lead candidate for the treatment of schizophrenia, AUT00206, …
homeopathy-1063292_640

FDA pledges to crack down on homeopathy treatments

December 19, 2017 Manufacturing and Production, Sales and Marketing FDA homeopathy, US, pharma

Following in the steps of authorities in the European Union, Australia and the United Kingdom, the FDA has pledged to …
doctor-563428_960_720

100,000 vacancies contribute to NHS crisis

December 19, 2017 Manufacturing and Production, Medical Communications NHS, UK, biotech, drugs, nurses, pharma, pharmaceutical

Warning shots have been fired by both the General Medical Council (GMC) and the Labour Party about the recruitment issues …
novartis_window

Novartis snaps up Priority Review Voucher for $130m

December 18, 2017 Manufacturing and Production, Sales and Marketing Novartis, Ultragenyx, biotech, drugs, pharma, pharmaceutical

Novartis has got its wallet out to pick up a Priority Review Voucher (PRV) from Ultragenyx, forking out $130 million …
rare-disease-2888820_960_720

Rare disease medicines access faces a perfect storm

December 18, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, rare disease

With access to rare disease treatments coming under increasing attention, both in the EU and the US, Pharmafile.com took the …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

December 15, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ionis, Sanofi, Teva, haemophilia, pharma, top ten

Just 10 days away from Christmas, and big news is still flowing in the industry. Sanofi remains embroiled in scandal …
The Gateway to Local Adoption Series

Latest content